|
Effect of Pharmaceutical Care Provision on Patients with Superficial Fungal Skin Infection Patients at Drug Stores |
|---|---|
| รหัสดีโอไอ | |
| Creator | Wiraphol Phimarn |
| Title | Effect of Pharmaceutical Care Provision on Patients with Superficial Fungal Skin Infection Patients at Drug Stores |
| Contributor | Yotsaya Kunlamas |
| Publisher | Faculty of Pharmaceutical Sciences KKU MSU UBU |
| Publication Year | 2556 |
| Journal Title | Isan Journal ofPharmaceutical Sciences |
| Journal Vol. | 9 |
| Journal No. | 3 |
| Page no. | 107-116 |
| Keyword | Pharmaceutical care, superficial fungal skin infection, pharmacist, drug store |
| URL Website | https://tci-thaijo.org/index.php/IJPS |
| Website title | Isan Journal ofPharmaceutical Sciences, IJPS |
| ISSN | 19050852 |
| Abstract | Introduction: Superficial fungal infections are a common disease presented by patients in drugstores. A community pharmacist should provide information about the disease, dispense appropriate antifungal drugs and identify and correct drug related problems. The objectives: To examine the effects of pharmaceutical care provision in patients with superficial fungal infections at four community pharmacies. Material and Methods: This quasi-experimental study investigated the knowledge about drugs and disease, treatment outcomes, relapse and compliance by comparing between a control group (patients who received routine service) and an intervention group (patients who received pharmaceutical care) between December 2009 and November 2010 in Mahasarakham. Fifty-seven patients with superficial fungal infections were recruited into the study; 30 patients were in the study group and 27 patients in the control group. Results: No significant differences were found in patients' characteristics between the groups. After pharmaceutical care provision, post test score of the experimental group was significantly higher than pre-test score (p<0.05) and significantly higher than the control group (p<0.05). On the other hand, there were no significant cure rate of patient in the experimental group were significantly higher than the control group (p<0.05). In addition, higher compliance and lower recurrence were found in the treatment group with significance difference (p<0.05). Conclusion: Pharmaceutical care provision for superficial fungal infections could increase knowledge about drugs and disease for patients who receive service, and increase compliance and lower recurrence rate. |
